Literature DB >> 24980508

Defining criteria for disease activity states in nonsystemic juvenile idiopathic arthritis based on a three-variable juvenile arthritis disease activity score.

Alessandro Consolaro1, Giorgia Negro, Maria Chiara Gallo, Giulia Bracciolini, Cristina Ferrari, Benedetta Schiappapietra, Angela Pistorio, Francesca Bovis, Nicolino Ruperto, Alberto Martini, Angelo Ravelli.   

Abstract

OBJECTIVE: To determine cutoff values for defining the states of inactive disease (ID), low disease activity (LDA; or minimal disease activity), moderate disease activity (MDA), and high disease activity (HDA) using the clinical (3-variable) Juvenile Arthritis Disease Activity Score (cJADAS).
METHODS: For selection of cutoffs, data from a clinical database including 609 children with juvenile idiopathic arthritis (JIA) were used. Optimal cutoffs were determined against external criteria by calculating the 75th and 90th percentile (for ID and LDA) and 10th and 25th percentile (for HDA) of cumulative score distribution and through receiver operating characteristic curve analysis. External criteria included definitions for ID and LDA cutoffs and therapeutic decisions for HDA cutoffs. MDA cutoffs were set at the score interval in-between LDA and HDA cutoffs. Crossvalidation was performed using 2 JIA patient samples (n = 485) and was based on assessment of construct and discriminant validity.
RESULTS: The selected cutoffs were as follows: ≤1 for ID in both oligoarthritis and polyarthritis; ≤1.5 and ≤2.5 for LDA in oligoarthritis and polyarthritis, respectively; 1.51-4 and 2.51-8.5 for MDA in oligoarthritis and polyarthritis, respectively; and >4 and >8.5 for HDA in oligoarthritis and polyarthritis, respectively. In crossvalidation analyses, the cutoffs showed a strong ability to discriminate between disease activity states defined subjectively by physicians and parents, levels of pain, and presence/absence of functional impairment and disease damage.
CONCLUSION: Cutoff values for classifying various disease states in nonsystemic JIA using the cJADAS were developed. The cutoffs revealed good measurement characteristics in crossvalidation analyses and are suited for application in clinical practice and research.
Copyright © 2014 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2014        PMID: 24980508     DOI: 10.1002/acr.22393

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  41 in total

1.  Paediatric rheumatic disease: What is the best definition of clinical remission in JIA?

Authors:  Gabriella Giancane; Angelo Ravelli
Journal:  Nat Rev Rheumatol       Date:  2017-06-29       Impact factor: 20.543

2.  Patient-Reported Outcomes Measurement Information System Tools for Collecting Patient-Reported Outcomes in Children With Juvenile Arthritis.

Authors:  Timothy G Brandon; Brandon D Becker; Katherine B Bevans; Pamela F Weiss
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-03       Impact factor: 4.794

3.  2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis.

Authors:  Sarah Ringold; Sheila T Angeles-Han; Timothy Beukelman; Daniel Lovell; Carlos A Cuello; Mara L Becker; Robert A Colbert; Brian M Feldman; Polly J Ferguson; Harry Gewanter; Jaime Guzman; Jennifer Horonjeff; Peter A Nigrovic; Michael J Ombrello; Murray H Passo; Matthew L Stoll; C Egla Rabinovich; Rayfel Schneider; Olha Halyabar; Kimberly Hays; Amit Aakash Shah; Nancy Sullivan; Ann Marie Szymanski; Marat Turgunbaev; Amy Turner; James Reston
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-04-25       Impact factor: 4.794

4.  2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis.

Authors:  Sarah Ringold; Sheila T Angeles-Han; Timothy Beukelman; Daniel Lovell; Carlos A Cuello; Mara L Becker; Robert A Colbert; Brian M Feldman; Polly J Ferguson; Harry Gewanter; Jaime Guzman; Jennifer Horonjeff; Peter A Nigrovic; Michael J Ombrello; Murray H Passo; Matthew L Stoll; C Egla Rabinovich; Rayfel Schneider; Olha Halyabar; Kimberly Hays; Amit Aakash Shah; Nancy Sullivan; Ann Marie Szymanski; Marat Turgunbaev; Amy Turner; James Reston
Journal:  Arthritis Rheumatol       Date:  2019-04-25       Impact factor: 10.995

Review 5.  Improving care delivery and outcomes in pediatric rheumatic diseases.

Authors:  Julia G Harris; Catherine A Bingham; Esi M Morgan
Journal:  Curr Opin Rheumatol       Date:  2016-03       Impact factor: 5.006

Review 6.  Current Research in Outcome Measures for Pediatric Rheumatic and Autoinflammatory Diseases.

Authors:  Erkan Demirkaya; Alessandro Consolaro; Hafize Emine Sonmez; Gabriella Giancane; Dogan Simsek; Angelo Ravelli
Journal:  Curr Rheumatol Rep       Date:  2016-02       Impact factor: 4.592

Review 7.  Innovative Research Design to Meet the Challenges of Clinical Trials for Juvenile Dermatomyositis.

Authors:  Silvia Rosina; Giulia Camilla Varnier; Marta Mazzoni; Stefano Lanni; Clara Malattia; Angelo Ravelli
Journal:  Curr Rheumatol Rep       Date:  2018-04-10       Impact factor: 4.592

8.  Evaluation of disease activity in a low-income juvenile idiopathic arthritis cohort.

Authors:  Francisco Airton Castro Rocha; Joaquim Ivo Vasques Dantas Landim; Marcela Gondim Aguiar; João Pedro Emrich Accioly; Carolina Noronha Lechiu; Luiza Helena Acácio Costa; Carlos Nobre Rabelo Júnior; Leila Nascimento da Rocha; Hermano Alexandre Lima Rocha
Journal:  Rheumatol Int       Date:  2018-08-13       Impact factor: 2.631

9.  Community poverty level influences time to first pediatric rheumatology appointment in Polyarticular Juvenile Idiopathic Arthritis.

Authors:  Nayimisha Balmuri; William Daniel Soulsby; Victoria Cooley; Linda Gerber; Erica Lawson; Susan Goodman; Karen Onel; Bella Mehta
Journal:  Pediatr Rheumatol Online J       Date:  2021-08-14       Impact factor: 3.054

10.  Mandibular range of motion in children with juvenile idiopathic arthritis with and without clinically established temporomandibular joint involvement and in healthy children; a cross-sectional study.

Authors:  Willemijn F C de Sonnaville; Caroline M Speksnijder; Nicolaas P A Zuithoff; Daan R C Verkouteren; Nico W Wulffraat; Michel H Steenks; Antoine J W P Rosenberg
Journal:  Pediatr Rheumatol Online J       Date:  2021-07-03       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.